JSB Market Research : Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy
The report, Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing.The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. See Full Report : http://bit.ly/1L29teX
The report, Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing.The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential.
See Full Report : http://bit.ly/1L29teX
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong><br />
<strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong> <strong>Future</strong> <strong>Strategy</strong><br />
Released On 16 th February 2015<br />
The leading pharmaceutical players continue <strong>to</strong> face <strong>the</strong> combined threats of a difficult operating<br />
environment <strong>and</strong> patent losses while struggling <strong>to</strong> deliver on pipeline potential. Externalization<br />
strategies are a key means <strong>to</strong> boost future revenues <strong>and</strong>, indeed more imminently, <strong>to</strong> satisfy<br />
shareholder dem<strong>and</strong>s. However, <strong>the</strong> increasing size of <strong>the</strong> leading biopharmaceutical companies<br />
is necessitating <strong>the</strong>ir involvement in growing <strong>the</strong> numbers <strong>and</strong> size of deals year by year. This in<br />
itself, along with <strong>the</strong> rising financial firepower of <strong>the</strong> mid-tier players, has increased <strong>the</strong> level of<br />
competition for <strong>the</strong> most attractive targets.<br />
Increased competition in <strong>the</strong> marketplace for M&A <strong>and</strong> licensing deals can artificially inflate <strong>the</strong><br />
cost of <strong>the</strong>se deals, dis<strong>to</strong>rting <strong>the</strong> balance of value, risk <strong>and</strong> return. As a result companies must<br />
employ more rigorous selection processes <strong>and</strong> exp<strong>and</strong> search criteria <strong>to</strong> consider more diverse<br />
options if <strong>the</strong>y are <strong>to</strong> maximize <strong>the</strong>ir returns on investment.<br />
The report, <strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong> <strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong><br />
<strong>Future</strong> <strong>Strategy</strong>, was written <strong>to</strong> support team <strong>and</strong> corporate strategic initiatives around <strong>the</strong> options<br />
that exist <strong>to</strong> grow revenues through externalization, whe<strong>the</strong>r by M&A or licensing. CBR Pharma<br />
Insights provides in-depth analysis on <strong>the</strong> deals being done <strong>to</strong>day, <strong>the</strong> trends being seen over<br />
time, <strong>and</strong> <strong>the</strong> strategies employed throughout <strong>the</strong> industry.<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Scope<br />
<strong>Trends</strong> in recent deal activity<br />
Successful deal making<br />
<strong>Future</strong> deal activity<br />
Key Reasons <strong>to</strong> Purchase<br />
Underst<strong>and</strong> <strong>and</strong> evaluate <strong>the</strong> strategies being used by companies of all sizes <strong>to</strong> support future<br />
revenue growth<br />
Benefit from CBRs case study analysis of <strong>the</strong> different types of deals being done in <strong>the</strong> current &<br />
future biopharma industry<br />
Access data <strong>and</strong> trends analysis of <strong>the</strong> types of deals taking place <strong>and</strong> which <strong>the</strong>rapeutic areas are<br />
showing <strong>the</strong> most activity<br />
Gain insights around <strong>the</strong> steps that need <strong>to</strong> be taken in order <strong>to</strong> best secure a successful deal<br />
Learn who <strong>the</strong> key companies are <strong>to</strong> watch for in <strong>the</strong> coming year, <strong>the</strong> motivations behind <strong>the</strong><br />
deals <strong>the</strong>y are doing, <strong>and</strong> identify which ones relate <strong>to</strong> your business strategies<br />
Browse complete Report on:<br />
http://www.jsbmarketresearch.com/healthcare-medical/r-<strong>Biopharma</strong>-MA-<strong>Deal</strong>-<br />
<strong>Making</strong>-Underst<strong>and</strong>ing-25040<br />
Table of Contents<br />
Executive Summary<br />
Chapter 1: Introduction<br />
What is driving <strong>the</strong> increased use of externalization in biopharma industry strategies<br />
Externalization strategies: <strong>the</strong> options<br />
Benefits of different deal types from M&A <strong>to</strong> arms length licensing<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Chapter 2: <strong>Trends</strong> in recent deal activity<br />
M&A deal trends<br />
Key acquisitions in 2012 <strong>and</strong> <strong>the</strong> motives behind <strong>the</strong>m<br />
Most acquisitive companies<br />
Licensing deal trends (Type of deal, Therapy area, Phase)<br />
Divesting - <strong>the</strong> o<strong>the</strong>r extreme<br />
Focus on: <strong>Deal</strong> activity in <strong>the</strong> generics sec<strong>to</strong>r<br />
Chapter 3: Successful deal making<br />
Key steps <strong>to</strong> successful deal making<br />
Shift <strong>to</strong> earlier stage deals<br />
Differentiating capabilities <strong>to</strong> position company as "partner of choice“<br />
Focus on: Joint ventures in emerging markets<br />
Chapter 4: <strong>Future</strong> deal activity<br />
Key companies <strong>to</strong> watch in 2013<br />
Appendix<br />
Exclusive discounts on reports of your choice till 28th February,2015:<br />
http://www.jsbmarketresearch.com/discount.php<br />
Product Price :<br />
License Type<br />
Price<br />
PDF $ 3900<br />
Site Licence $ 4900<br />
Enterprise Wide Licence $ 9800<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Related reports:<br />
Electronic Health Records - Charting <strong>the</strong> <strong>Future</strong> of Health Care<br />
Reformulation Strategies - New Technologies Extend Use Beyond Lifecycle<br />
Management<br />
Looking at Senior Long-term Care - Where will <strong>the</strong> market go<br />
Risk Evaluation <strong>and</strong> Mitigation Strategies - Adaptation in an evolving system<br />
The Impact of Generics on Pharmaceutical Growth Opportunities - A growing<br />
threat that offers future opportunities<br />
Accelerating Drugs <strong>to</strong> <strong>Market</strong> - In Search of Opportunity Along <strong>the</strong> Drug<br />
Development & Approval Pathway<br />
New Product Launch Strategies - Initiating <strong>Market</strong> Entry with Sound Strategies<br />
<strong>and</strong> Tactics<br />
Pharmaceutical Sales Force Effectiveness - Rethinking <strong>the</strong> Current Sales Model<br />
Pharmaceutical Cliff Diving - Assessing <strong>the</strong> key challenges that will re-shape <strong>the</strong><br />
industry<br />
Healthcare <strong>and</strong> Medical <strong>Market</strong> <strong>Research</strong><br />
You can order this report by calling on +91 - 998 7295 242 or mail us your<br />
contact details at contact@jsbmarketresearch.com<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
About <strong>JSB</strong> <strong>Market</strong> <strong>Research</strong>:-<br />
<strong>JSB</strong> market research is a leading player in <strong>the</strong> market of research report distribution. It is ones<strong>to</strong>p-shop<br />
for all information related <strong>to</strong> market research for any sec<strong>to</strong>r of <strong>the</strong> industry. Along with<br />
providing in-depth analysis though reports, <strong>JSB</strong> market research also provides regular updates of<br />
<strong>the</strong> market though newsletters. Our reports are a well-researched work of market researchers with<br />
an extensive knowledge <strong>and</strong> a good level of market experience.<br />
To know more on “<strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong><br />
<strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong> <strong>Future</strong> <strong>Strategy</strong>”<br />
http://www.jsbmarketresearch.com/healthcare-medical/r-<strong>Biopharma</strong>-MA-<strong>Deal</strong>-<strong>Making</strong>-<br />
Underst<strong>and</strong>ing-25040<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/